IMAPAC Glossary

A glycoprotein is a protein with covalently attached carbohydrate chains that influence its structure, stability, activity and biological recognition.

Glycoprotein processing pathways describe the cellular mechanisms responsible for protein folding, glycosylation, maturation and intracellular transport.

A glycosaminoglycan is a long linear polysaccharide that contributes to extracellular matrix structure, cell signalling and molecular interactions.

Glycosylation is the enzymatic addition of carbohydrate groups to proteins or lipids, affecting their structure, activity, stability and therapeutic performance.

Glycosylation pattern analysis characterises the carbohydrate structures attached to proteins to assess product quality, consistency and biological function.

A GMP deviation is any departure from an approved manufacturing procedure, specification or quality requirement that must be investigated and documented.

GMP validation is the documented demonstration that manufacturing processes, methods, equipment and systems consistently perform according to predefined requirements.

Good Clinical Practice is the international ethical and scientific standard for conducting clinical trials while protecting participants and ensuring reliable data.

Good Laboratory Practice (GLP) is a quality system governing non-clinical laboratory studies to ensure research supporting regulatory submissions is planned, conducted, monitored and reported reliably.

Good Manufacturing Practice compliance ensures pharmaceutical products are consistently manufactured, controlled and documented according to established regulatory quality standards.

Good Manufacturing Practice (GMP) is a quality system governing pharmaceutical manufacturing to ensure products are consistently produced, controlled and documented to meet established quality standards.

A G-protein-coupled receptor is a cell-surface receptor that transmits extracellular signals through intracellular G proteins to regulate biological responses.

Gradient high-performance liquid chromatography separates complex mixtures using a changing mobile-phase composition to improve analytical resolution and sensitivity.

Growth factor receptor targeting uses therapeutic agents to selectively modulate growth factor receptors involved in disease progression, particularly cancer.

Haemagglutinin is an influenza virus surface glycoprotein that binds host cell receptors and mediates viral entry, making it the primary target of influenza vaccines.

Haematopoiesis is the regulated process by which haematopoietic stem cells generate and replenish all blood cell types throughout life.

Half-life is the time required for the concentration of a drug or biologic in the body to decrease by 50%, influencing dosing frequency and therapeutic exposure.

A hapten is a small molecule that becomes immunogenic only when attached to a larger carrier protein, forming an antigen capable of triggering immune responses.

Health economic modelling predicts the clinical and economic value of healthcare interventions to support reimbursement, policy and resource allocation decisions.

Health-related quality of life measures the impact of disease and treatment on a patient's physical, mental, emotional and social wellbeing.

Heat Shock Proteins (HSPs) are molecular chaperones that protect cells by supporting protein folding, preventing aggregation and promoting the degradation of misfolded proteins.

Helminth therapy is an experimental approach that uses parasitic worms or their molecules to regulate immune responses for treating autoimmune and inflammatory diseases.

Heparin is a highly sulphated glycosaminoglycan anticoagulant that enhances antithrombin activity to prevent and treat thromboembolic disorders.

Hepatotoxicity is liver injury caused by drugs, chemicals or biological agents, ranging from mild enzyme abnormalities to severe liver failure.

Hepatotoxicity risk assessment evaluates the potential for a therapeutic product to cause liver injury during development or clinical use.

High-Content Screening is an imaging-based analytical method that uses automated microscopy and quantitative image analysis to evaluate complex cellular responses.

A highly potent active pharmaceutical ingredient (HPAPI) is an active substance with significant biological activity that requires specialised containment during manufacture.

High Throughput Screening (HTS) is an automated drug discovery approach that rapidly tests large compound libraries against biological targets using miniaturised, high-capacity assays.

High-throughput screening impact evaluates how automated large-scale screening technologies improve target identification, compound selection and drug discovery efficiency.

A histamine release assay measures histamine secretion from immune cells to evaluate allergic reactions, hypersensitivity or biological activity.

Histidine buffer is a pharmaceutical formulation buffer that maintains stable pH and supports the stability of biologics such as monoclonal antibodies and recombinant proteins.

Histological tissue examination analyses tissue architecture and cellular morphology under the microscope to support diagnosis, research and pathological assessment.

Homogeneity of variance testing determines whether variability is consistent across comparison groups to support valid statistical analysis.

Host Cell Protein (HCP) refers to residual proteins from production host cells that remain as process-related impurities in biologic products and require strict control.

Host immune response modulation alters immune system activity to enhance therapeutic efficacy, reduce inflammation or improve disease control.

Human Factors Engineering is the discipline of designing medical products and devices to reduce user errors and improve safety through human-centred design principles.

A humanised antibody is an engineered antibody that combines non-human antigen-binding regions with human antibody frameworks to reduce immunogenicity while retaining target specificity.

Humidity stability profiling evaluates how exposure to moisture influences the quality, stability and shelf life of pharmaceutical products.

Humoral immunity is the antibody-mediated branch of the immune system that protects against pathogens through neutralisation, opsonisation and complement activation.

A hybridoma is an immortalised cell line created by fusing an antibody-producing B cell with a myeloma cell to enable continuous monoclonal antibody production.

Hydration status monitoring assesses body fluid balance using clinical measurements or biomarkers to support patient management and therapeutic decision-making.

A hydrogel is a three-dimensional network of hydrophilic polymers that absorbs large amounts of water while supporting controlled drug delivery and tissue engineering applications.

Hypersensitivity reaction management comprises strategies to prevent, recognise and treat immune-mediated allergic reactions associated with medicines or biological products.

Hypoxia-inducible factor targeting modulates cellular responses to low oxygen by regulating hypoxia-responsive signalling pathways for therapeutic benefit.

An immunoassay is an analytical technique that uses antibody-antigen interactions to detect and quantify specific biological molecules with high sensitivity and specificity.

Immunofluorescence technique application uses fluorescently labelled antibodies to detect and localise specific proteins or antigens within cells and tissues.

Immunogenicity is the ability of a therapeutic product to trigger immune responses that may affect its safety, efficacy or pharmacokinetic profile.

Immunohistochemistry (IHC) is a laboratory technique that uses antibodies to detect and localise specific proteins within preserved tissue sections.

Immunosuppressant trough monitoring measures the lowest concentration of immunosuppressive medicines before the next dose to optimise efficacy and minimise toxicity.

Immunotherapy comprises treatments that harness or modulate the immune system to prevent or treat diseases, particularly cancer.

Impurity profiling strategy identifies, characterises and controls impurities throughout pharmaceutical development to ensure product quality and patient safety.

IND-enabling studies are the preclinical studies and development activities required to support submission of an Investigational New Drug application before first-in-human trials.

An induced pluripotent stem cell (iPSC) is an adult somatic cell reprogrammed into a pluripotent state capable of differentiating into almost any cell type.

An inducible expression system is a genetic system that enables controlled gene expression in response to specific external stimuli such as chemicals, temperature or light.

Induction period characterisation evaluates the time between treatment initiation and the onset of measurable biological or therapeutic effects.

Informed consent is the ethical and regulatory process through which individuals voluntarily agree to participate in research after receiving adequate information about the study.

Informed consent process optimisation improves the clarity, accessibility and effectiveness of participant consent procedures while maintaining ethical and regulatory standards.

An infusion reaction is an adverse response occurring during or shortly after intravenous administration of a therapeutic product, particularly biologics.

In silico refers to computational methods that use computer models, simulations and algorithms to support biomedical research and drug development.

In situ hybridisation is a molecular technique that detects specific DNA or RNA sequences within intact cells or tissues while preserving their spatial context.

An integrated data management system combines data from multiple sources into a unified platform to improve traceability, analysis and regulatory compliance.

Intellectual Property (IP) comprises legal rights protecting inventions, innovations and proprietary knowledge, including patents, trade secrets and regulatory exclusivities.

Interleukins (ILs) are cytokines that regulate immune responses, inflammation, cell growth and differentiation through receptor-mediated signalling pathways.

An internal control is a reference sample or signal included in an assay to verify that analytical procedures are functioning correctly and producing reliable results.

Intramuscular administration site selection identifies the most appropriate injection location to maximise therapeutic delivery while minimising complications.

An Investigational Medicinal Product (IMP) is a pharmaceutical product or placebo used or tested in a clinical trial under controlled regulatory requirements.

An Investigational New Drug (IND) application is a regulatory submission requesting authorisation to begin clinical testing of a new therapeutic candidate in humans.

Investigator qualifications assessment verifies that clinical investigators possess the education, training and experience required to conduct studies in compliance with regulations.

In vitro describes biological studies or experiments performed outside living organisms using isolated cells, tissues or biochemical systems under controlled laboratory conditions.

An in vitro metabolism study evaluates how therapeutic compounds are metabolised using isolated enzymes, cells or biological systems under laboratory conditions.

In vivo describes biological processes, experiments or therapeutic effects occurring within intact living organisms, including animal models and human studies.

In vivo imaging comprises non-invasive imaging technologies that visualise biological processes, anatomy and therapeutic responses within living organisms.

An isoenzyme is a structurally distinct form of an enzyme that catalyses the same biochemical reaction but differs in tissue distribution or regulatory properties.

Isomeric separation methodology distinguishes molecules with identical molecular formulas but different structures using advanced analytical separation techniques.

Isothermal Titration Calorimetry (ITC) is a label-free biophysical technique that measures heat released or absorbed during molecular interactions to determine binding properties.

Isotope labelling is a technique that incorporates stable or radioactive isotopes into molecules to trace metabolic pathways, molecular interactions and biological processes.

A JAK inhibitor is a small-molecule drug that blocks Janus kinase enzymes to reduce cytokine signalling and suppress inflammatory and immune responses.

The JAK-STAT pathway is an intracellular signalling pathway that transmits cytokine and growth factor signals to regulate gene expression, immunity and inflammation.

The Janssen Effect describes the tendency for promising early clinical trial results to diminish when evaluated in larger, more representative studies.

Japan PMDA is Japan's regulatory agency responsible for evaluating, inspecting and monitoring pharmaceuticals, biologics, medical devices and regenerative medicine products.

Jaundice is the yellow discoloration of the skin and eyes caused by elevated bilirubin concentrations, often indicating liver or biliary dysfunction.

J-Chain is a small polypeptide that enables polymerisation of IgA and IgM antibodies and supports their transport across mucosal surfaces.

The J-Curve Effect describes a relationship in which both very low and very high values are associated with increased risk, with optimal outcomes occurring within an intermediate range.

Jejunal transporter expression examines the distribution and activity of transport proteins within the jejunum that influence nutrient and drug absorption.

JIT inventory risk is the vulnerability created by maintaining minimal inventory levels, increasing exposure to supply chain disruptions and material shortages.

Job lot release is the formal quality authorisation permitting a manufactured batch to be released after confirming compliance with predefined specifications.

Joint injection technique describes the correct administration of therapeutic agents into synovial joints to maximise efficacy and minimise procedural complications.

Joint toxicity assessment evaluates the combined toxicological effects of multiple substances following simultaneous or sequential exposure.

A joint venture (JV) is a strategic partnership in which two or more organisations share resources, investment and operational responsibilities to achieve defined business objectives.

Journal Impact Factor is a bibliometric measure representing the average citation frequency of articles published in a scientific journal over a defined period.

Judgement bias mitigation implements structured methods to reduce subjective bias during scientific evaluation, clinical assessment and regulatory decision-making.

Junctional adhesion complex function describes the role of specialised protein complexes in maintaining cell-cell adhesion, tissue integrity and signalling.

A junctional epitope is an antigenic region formed where two protein domains are joined, potentially increasing immunogenicity in engineered therapeutic proteins.

Junctional integrity preservation maintains the structure and function of cellular junctions to support tissue barrier function and normal physiological processes.

Jurisdiction is the legal or regulatory authority under which pharmaceutical development, manufacturing, approval and compliance activities are governed.

Jurisdiction-specific requirements are the regulatory obligations unique to individual countries or regions governing pharmaceutical development and approval.

Justification of dose selection provides the scientific and clinical rationale supporting the chosen dose for preclinical studies or clinical development.

Justification of risk-benefit is the evaluation demonstrating that the anticipated therapeutic benefits of a product outweigh its potential risks for the intended population.

Justification of sample size is the statistical rationale demonstrating that a clinical or preclinical study includes sufficient participants to achieve reliable and meaningful results.

Just-in-Time (JIT) manufacturing is a production approach that minimises inventory by manufacturing and delivering materials only when required.